Skip to main content
. 2016 Jul 29;8:53. doi: 10.1186/s13098-016-0167-z

Fig. 1.

Fig. 1

24-h CGM data for 101 type 1 diabetic patients on basal-bolus insulin therapy as stratified equally by HbA1c value. Group A, HbA1c ≤7.2 %; group B, 7.2 % <HbA1c ≤8.2 %; group C, 8.2 % <HbA1c ≤ 9.2 %; and group D, HbA1c >9.2 %